Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Hologic makes medical tests, imaging machines, and surgical tools focused on women's health.
Hologic is a medical technology company built around women's health. Its best-known product is the Pap test and the lab machines that run it, which screen for cervical cancer. It also sells 3D mammography systems that create a detailed picture of breast tissue, and surgical devices used to treat conditions like heavy periods and fibroids. The thread running through all of it is helping doctors catch and treat problems in women's bodies earlier and less invasively.
The company makes money in two main ways. One is selling the instruments and lab equipment themselves, often to hospitals and clinics. The other, and the stickier part, is the steady stream of consumables and tests that those machines need to keep running. Once a lab or hospital buys a Hologic system, it tends to keep buying Hologic's tests and supplies for years. That razor-and-blades setup gives the business a reliable, recurring feel rather than a one-and-done sales cycle. Its customers are mostly hospitals, diagnostic labs, imaging centers, and doctors' offices, mainly in the United States. The pitch to them is accuracy and early detection: a clearer mammogram or a more precise cervical cancer screen can catch disease sooner. Hologic has grown partly by buying other companies to widen its lineup, and it battles rivals across each segment, including big imaging players like GE HealthCare and diagnostics and surgical competitors. One honest caveat: this is not a high-flying growth story. Revenue has been roughly flat to modestly growing in recent years, partly because the pandemic briefly turned it into a big seller of COVID-19 tests and that surge faded. Management has leaned on steady cash flow to buy back a meaningful chunk of its own shares and make bolt-on acquisitions. For years Hologic traded publicly on the Nasdaq, but reliable sources now say its shares no longer trade, meaning the company has been taken private or absorbed rather than standing as an independent listed stock.
The bigger picture is a focused, cash-generating business that sells unglamorous but essential tools to the people who screen and treat women. It is not trying to be a general-purpose health giant. It picks a lane, sells the machines, then quietly collects the recurring revenue from the tests and supplies that keep those machines busy.
Saved answer · last researched 15 Nov 2026